(Allergan plc)

	AGN latest price $214.3339 (-0.33%) ($207.6260 - $218.5034) on Tue. Oct. 14, 2014.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.51% (three month average)
RSI	27
Latest Price	$214.3339(-0.33%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -1.8% a day on average for past five trading days.
Weekly Trend	AGN declines -2.3% a week on average for past two weeks.
Market Behavior	Normal for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(56%)    XBI(47%)    SPY(44%)    QQQ(42%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -0.755% in a week (0% probabilities).   VIXM(-32%)    TLT(-19%)    SHY(-8%)    IGOV(-5%)    GLD(-5%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.755% (StdDev 1.51%)
Hourly BBV	0 ()
Intraday Trend	-1%

Resistance Level	$231.23
5 Day Moving Average	$225.93(-5.13%)
10 Day Moving Average	$229.24(-6.5%)
20 Day Moving Average	$231.23(-7.31%)
To recent high	-10.5%
To recent low	9.5%
Market Cap	$70.666b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed